As these gene associations have not yet been studied in the Japanese population, we evaluated whether HLA-KIR interactions, in addition to an IL28B polymorphism, would influence the outcome of pegylated-interferon-α (PEG-IFN) and ribavirin therapy in Japanese patients with chronic hepatitis C. This evidence concerns the gene KIR3DL1 and chronic hepatitis C virus infection.